HIV positive patient treated with ixekizumab.
HIV
Psoriasis
psoriasis treatment
Journal
La Clinica terapeutica
ISSN: 1972-6007
Titre abrégé: Clin Ter
Pays: Italy
ID NLM: 0372604
Informations de publication
Date de publication:
25 May 2022
25 May 2022
Historique:
entrez:
25
5
2022
pubmed:
26
5
2022
medline:
28
5
2022
Statut:
ppublish
Résumé
Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.
Identifiants
pubmed: 35612328
doi: 10.7417/CT.2022.2416
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
ixekizumab
BTY153760O
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM